Bring the World's Most Advanced Chronic Disease Algorithm to Your City
We are engineering a network of 50 corporate hospitals across major Indian metropolitans. If you own or operate a 100–150 bed hospital and want to leapfrog Apollo and KIMS — not by building from scratch, but by integrating the world's most exclusive medical technology — the Anjaniputra Franchise is the only path.
Investment
₹10 Crore
Covers technology, equipment, and IP licensing
Space Required
10,000 sq ft
Minimum dedicated clinical space within your facility
Facility Type
100–150 Bed Hospital
Existing hospital owners preferred
Revenue Target
₹5–6 Crore / month
At operational maturity — per facility
The Complete Anjaniputra Package
Everything you need to deliver the world's most advanced chronic disease algorithm in your city.
Full Anjaniputra Algorithm integration
Exclusive technology transfers (Israel, Switzerland, New Zealand, Germany, UK, USA)
Training & certification via Anjaniputra Academy™
Access to international expert advisory network
Proprietary pharmacy & supplement license
Brand, marketing & digital integration support
Ongoing clinical protocol updates and research access
Revenue model guidance and operational support
Training Ecosystem
Your physicians will be certified in protocols unavailable anywhere else in India through the Anjaniputra Academy™. Over time, even Apollo and KIMS physicians will seek certification from your facility — positioning you as the regional training hub for biological medicine.
Expansion Logic
Once your facility hits the ₹5–6 Crore per month threshold, the system is self-sustaining and we activate the next metropolitan location together. This is not a one-time transaction — it is a partnership in building India's most advanced chronic disease network.
Target: 50 corporate facilities across Indian metropolitans by 2030.
Is This For You?
The Anjaniputra Franchise is designed for a specific type of hospital leader.
Hospital Owners
100–150 bed facilities seeking to leapfrog Apollo and KIMS by accessing technology their physicians cannot access elsewhere.
Healthcare Investors
Investors seeking a proven, IP-protected, revenue-generating healthcare model with a clear path to ₹5–6 Cr/month.
Hospital Networks
Multi-location operators looking to differentiate their network with exclusive technology unavailable to competitors.
Whether you are seeking answers for a chronic condition or exploring regenerative medicine — we have a pathway for you.
Our care team is ready to match you with the right specialist and the world's most advanced treatment protocol.